TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Bioplanum AB
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
550
|
671
|
421 |
| Financial expenses |
5
|
4
|
1 |
| Earnings before taxes |
223
|
104
|
126 |
| EBITDA |
227
|
107
|
127 |
| Total assets |
261
|
334
|
330 |
| Current assets |
241
|
315
|
310 |
| Current liabilities |
35
|
173
|
149 |
| Equity capital |
226
|
161
|
180 |
| - share capital |
51
|
47
|
49 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
86.6%
|
48.2%
|
54.5% |
| Turnover per employee |
550
|
671
|
421 |
| Profit as a percentage of turnover |
40.5%
|
15.5%
|
29.9% |
| Return on assets (ROA) |
87.4%
|
32.3%
|
38.5% |
| Current ratio |
688.6%
|
182.1%
|
208.1% |
| Return on equity (ROE) |
98.7%
|
64.6%
|
70.0% |
| Change turnover |
-168
|
262
|
80 |
| Change turnover % |
-23%
|
64%
|
23% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.